Jamieson has advised CEO Norman Smith and the management team of Vision RT on the acquisition of a majority stake in the business by the Danish medtech investment company, William Demant Invest (WDI). WDI is a long-term, evergreen investor with considerable medical device industry experience.
Following almost 17 years since its inception, Vision RT, the leading supplier of Surface Guided Radiation Therapy (SGRT) has transferred the majority of its longstanding privately held shareholding to WDI. Vision RT’s founders, Norman Smith, Gideon Hale and Ivan Meir continue as shareholders and the company will remain in its previous standalone form, with the same strategy, structure and management as before.
The management team were advised by Tom Burton and Ross Wheeler on their investment and the new management incentive plan.